ASHP updates policies, procedures for drug shortages
[raw] The American Society of Health-System Pharmacists (ASHP) has released updated guidance on the management of drug shortages, which focuses on policies and procedures that help minimize the effects of drug shortages on the quality of care. “The current situation...
read more
Who should get the flu shot? When should I get it?
The best way to prevent getting the flu and spreading it is to get a flu vaccine. The vaccine is also the best way to make flu symptoms less severe if you do get the flu. Everyone 6 months of age and older should get the vaccine every year. Certain groups...
read more
Stronger Warnings (Again) for Fluoroquinolones
The FDA is requiring strengthened warnings for fluoroquinolone antibiotics (ciprofloxacin, delafloxacin, levofloxacin, moxifloxacin, ofloxacin) – this time for mental health side effects and serious blood sugar disturbances. These are the latest in a series of...
read more
Influenza Update
This issue provides key information on influenza vaccines and antiviral medications for the 2018-2019 flu season, including precautions, side effects, and use in special populations. Influenza (commonly referred to as “the flu”) is a contagious viral infection of the...
read more
Common Medications May Be Contributing to Depression
The use of medications with depression as a side effect may be contributing to the growing problem of depression, according to a new study. The study used data from the National Health and Nutrition Examination Survey (NHANES) – over 26,000 adults were surveyed every...
read moreU.S. Food and Drug Administration Approves SIGA Technologies’ TPOXX® (tecovirimat) for the Treatment of Smallpox
NEW YORK, July 13, 2018 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ:SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that the U.S. Food and Drug Administration (FDA) has approved oral TPOXX®...
read more
Medication Adherence: Resources for More Information
Food and Drug Administration Drug Information for Consumers: https://www.fda.gov/Drugs/ResourcesForYou/Consumers/default.htm National Council on Aging Benefits Checkup: https://www.benefitscheckup.org American Society of Health System Pharmacists My...
read more
Barbershop-Managed Hypertension
Non-hispanic black men have a higher rate of hypertension-related death than any other racial group in the US. In a recent study involving 52 black-owned barbershops in the Los Angeles area, barbers encouraged their regular black male customers (35 - 79 years old) to...
read more
Managing Psoriasis
This issue will bring you up to date on the impact of Psoriasis and recent developments in drug therapy. Key Takeaways: • Psoriasis is recognized as an immunemediated, chronic, systemic inflammatory condition. • About 80% of patients with mild to moderate psoriasis...
read more
Pimavanserin – Reexamined After Reports of Death
Pimavanserin (Nuplazid™), the first atypical antipsychotic for Parkinson’s disease (PD) - related psychosis (eg, hallucinations and delusions), received FDA priority review and approval in 2016. Like other atypical antipsychotics, it carries a black box warning about...
read moreAbout The Rx Consultant
The Rx Consultant is a subscription-based service that delivers practical updates, continuing education & reviews covering all the top-selling drugs and common health conditions. All our publications focus on the facts busy front-line pharmacists, nurse practitioners and pharmacy technicians need to stay current.
Each issue contains a drug therapy update with CE, patient Q&A, healthcare news, charts & tables and quick facts cards. The Continuing Education Network is an ACPE approved provider - credit for pharmacists is automatically reported to CPE Monitor. Our CE meets ANCC & AANP criteria, allowing nurse practitioners to fulfill their pharmacology CE needs.
The Rx Consultant has subscribers throughout the United States, Canada & The UK.